DUSP1 and pancreatic neoplasm: Taken together, these results suggest that interrupting the negative feedback on p38 MAPK and JNK signaling by suppressing DUSP1 could enhance apoptosis and improve the chemosensitivity of pancreatic cancer to multiple chemotherapeutic agents.